Mylan N V (MYL) Inventory Turnover Ratio, from third quarter 2020 to third quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Mylan N v   (NASDAQ: MYL)
 

Mylan N V Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2020, Mylan N V 's inventory turnover ratio sequentially decreased to 2.64 in the third quarter 2020, otherwise the ratio remained above the average, as MYL's markets remain strong.Mylan N V 's average inventory processing period in the Sep 30 2020 quarter, has increased to 138 days, from 134 days, in the Jun 30 2020 quarter.

Within Healthcare sector 186 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1091 in the second quarter 2020, to 1094.

MYL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Mylan N V Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYL Inventory Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Inventory Growth 9.35 % 0.34 % -2.55 % 3.52 % 7.92 %
Y / Y Cost of Sales Growth -4.01 % -11.12 % 1.35 % 2 % 3.63 %
Inventory Turnover Ratio (TTM) 2.64 2.73 2.81 2.79 2.79
MYL's Total Ranking # 1094 # 1091 # 1094 # 1094 # 1091
Average inventory processing period 138 134 130 131 131
Seq. Inventory Growth 8.48 % 5.53 % -1.17 % -3.35 % -0.46 %
Seq. Cost of Sales Growth 6.34 % -0.44 % -18.59 % 11.39 % -1.54 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 57
Healthcare Sector # 187
Overall Market # 1094

Inventory Turnover Ratio Statistics
High Average Low
2.87 2.58 1.73
(Dec 31 2018)   (March 31 2014)



MYL Company Profile >> Back to MYL Efficiency Comparisons >> Compare MYL Inventory Turnover Ratio to its Competitors

Financial Statements
Mylan N V 's Inventories $ 3,022 Millions Visit MYL's Balance sheet
Mylan N V 's Cost of Revenues TTM $ 7,337 Millions Visit MYL's Income Statement
What are MYL's Sales? Visit MYL's Sales by Segment

Other Inventory Turnover Ratios
Mylan N V 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MYL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MYL's Competitors
Inventory Turnover Ratio for MYL's Suppliers
Inventory Turnover Ratio for MYL's Customers

You may also want to know
MYL's Sales Growth Rates MYL's Pe Price to earnings ratio MYL's Receivables Turnover Ratio MYL's Stock Quote
MYL's Net Income Growth Rates MYL's Ps Price to Sales ratio MYL's Sales per Employee MYL's Asset Turnover Ratio
MYL's Net Margin MYL's Pb Price to Book ratio MYL's Financial Strength Ratios MYL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2020 Inventories at quarter ending Sep 30 2020
Caredx Inc   6.58 $ 52.033  Millions$ 8  Millions
Healthlynked Corp  6.57 $ 0.609  Millions$ 0  Millions
Zai Lab Limited  6.56 $ 13.663  Millions$ 2  Millions
Genmark Diagnostics Inc   6.53 $ 91.007  Millions$ 14  Millions
Clearday Inc   6.51 $ 0.760  Millions$ 0  Millions
Castle Biosciences Inc   6.22 $ 9.023  Millions$ 1  Millions
Catalyst Pharmaceuticals Inc   6.17 $ 16.568  Millions$ 3  Millions
Fonar Corporation  6.13 $ 10.538  Millions$ 2  Millions
Stablecoin Development Corporation  6.11 $ 3.750  Millions$ 1  Millions
Nexgel Inc   6.04 $ 0.831  Millions$ 0  Millions
Carlisle Companies Incorporated  5.86 $ 3,126.800  Millions$ 533  Millions
Avid Bioservices Inc   5.85 $ 58.143  Millions$ 10  Millions
Camp4 Therapeutics Corporation  5.81 $ 215.468  Millions$ 37  Millions
Avantor Inc   5.77 $ 4,133.600  Millions$ 716  Millions
Lantheus Holdings Inc   5.71 $ 189.929  Millions$ 33  Millions
Twist Bioscience Corporation  5.63 $ 61.405  Millions$ 11  Millions
Patterson Companies Inc   5.55 $ 4,361.575  Millions$ 785  Millions
Aquestive Therapeutics Inc   5.49 $ 16.968  Millions$ 3  Millions
Align Technology inc   5.44 $ 662.478  Millions$ 122  Millions
Myriad Genetics Inc   5.30 $ 156.200  Millions$ 29  Millions
Cytosorbents Corporation  5.25 $ 10.620  Millions$ 2  Millions
Idexx Laboratories Inc  5.17 $ 1,102.705  Millions$ 213  Millions
Inogen Inc   5.06 $ 175.383  Millions$ 35  Millions
West Pharmaceutical Services Inc   5.03 $ 1,327.400  Millions$ 264  Millions
Gilead Sciences Inc   4.90 $ 4,857.000  Millions$ 992  Millions
Mallinckrodt Plc  4.88 $ 1,603.500  Millions$ 329  Millions
Henry Schein Inc   4.87 $ 6,857.127  Millions$ 1,407  Millions
Adm Tronics Unlimited Inc   4.86 $ 1.952  Millions$ 0  Millions
Orgenesis Inc   4.81 $ 3.002  Millions$ 1  Millions
T2 Biosystems Inc   4.79 $ 17.415  Millions$ 4  Millions

Date modified: 2026-09-08T15:10:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.